Eremenco, Sonya http://orcid.org/0000-0003-3956-0235
Chen, Wen-Hung
Blum, Steven I.
Bush, Elizabeth Nicole
Bushnell, Donald M.
DeBusk, Kendra
Gater, Adam
Nelsen, Linda
Coons, Stephen Joel http://orcid.org/0000-0001-7977-5156
,
Article History
Accepted: 18 June 2022
First Online: 19 July 2022
Declarations
:
: Sonya Eremenco is currently a full-time employee of Critical Path Institute and was so employed for the duration of manuscript development. Wen-Hung Chen is currently a full-time employee of GlaxoSmithKline, Collegeville, PA, USA, and GSK stockholder. At the time the studies were conducted and at the start of this manuscript, Mr. Chen was employed by the US Food and Drug Administration. Steven I. Blum is currently a full-time employee of Bristol Myers Squibb, Lawrenceville, NJ, USA and a BMS stockholder. At the time the studies were conducted and at the start of this manuscript, Mr. Blum was employed by the GlaxoSmithKline. Elizabeth Nicole Bush is currently a full-time employee of Eli Lilly and Company and a stockholder and was so employed at the time the studies were conducted and for the duration of manuscript development. Donald M. Bushnell is currently a full-time employee of Evidera | PPD. At the time the studies were conducted and at the start of this manuscript, Mr. Bushnell was employed by Health Research Associates, Inc. Kendra DeBusk is currently a full-time employee of Seagen Inc., Bothell, WA, USA, and a Seagen stockholder. At the time the studies were conducted and at the start of this manuscript, Dr. DeBusk was employed by Genentech Inc. Adam Gater is currently a full-time employee of Adelphi Values, UK, and was so employed at the time the studies were conducted and for the duration of manuscript development. Linda Nelsen is currently a full-time employee of GlaxoSmithKline and a stockholder and was so employed at the time the studies were conducted and for the duration of manuscript development. Stephen Joel Coons is currently a full-time employee of Critical Path Institute and was so employed at the time the studies were conducted and for the duration of manuscript development. The authors have no relevant financial or non-financial interests to disclose.
: All procedures performed in studies involving human participants were in accordance with the principles of the Declaration of Helsinki. Approval for the <i>SMDDS</i> study was granted by Quorum IRB (#29844 dated October 1, 2014). Approval for the <i>ADSD</i>/<i>ANSD</i> study was granted by Copernicus Group IRB (#QP6579B on June 5, 2015). Approval for the <i>NSCLC-SAQ</i> study was granted by Quorum IRB (#30260 on February 16, 2016, and Amendment 1 on March 2, 2016).
: Informed consent was obtained from all individual adult participants included in the studies reported here. For the adolescents in the <i>ADSD</i>/<i>ANSD</i> study, written informed consent was obtained from parents/guardians of the participants and written assent was obtained from the adolescent participants.
: This is not applicable to this article as no individual person’s data in any form is included.